Financials
Financial year 2025
Signifeye from Antwerpen, company number BE0884161037, closed financial year 2025 with a result of € 6 million after tax. For that financial year Signifeye recorded a gross margin of € 2.3 million and equity of € 14.2 million. Compared with financial year 2024, the result moved from € 752,865 to € 6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 14.2 million
▲ 92% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6 million
▲ € 5.2 million vs 2024
Profit after tax over the fiscal year.
€ 230,392
▼ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 6.3 million.
Debts at end 2025
€ 4.3 million
▼ 52% vs 2024
€ 1.4 million is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 234,337
▲ 45% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,176
▼ 26% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 1,585,733 | € 2,757,364 | - | |
| Gross margin | € 717,716 | - | - | € 2,262,045 | |
| Profit after taxes | € 580,283 | € -725,122 | € 752,865 | € 5,995,848 | ▲ € 5.2 million |
| Equity | € 330,995 | € 5,185,872 | € 7,388,737 | € 14,174,585 | ▲ 92% |
| Total debts | € 943,988 | € 10,575,567 | € 9,217,794 | € 4,545,146 | ▼ 51% |
| Cash | € 828,770 | € 465,067 | € 238,959 | € 230,392 | ▼ 4% |
| Retained profit | € 269,495 | € -455,628 | € 297,237 | € 6,293,085 | ▲ € 6 million |
| Dividend | € 830,000 | € 0 | € 0 | € 0 | |
| Bank debt | € 0 | € 10,412,015 | € 8,981,330 | € 4,284,257 | ▼ 52% |
| Balance sheet total | € 1,274,983 | € 15,761,439 | € 16,606,531 | € 18,719,731 | ▲ 13% |
By gross margin, Signifeye ranks 2nd of 7 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Antwerpen that publish figures (fiscal year 2025).
Key figures of Signifeye, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Signifeye the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Signifeye?
What happened at Signifeye in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Bernard Heintz stepped down as director. NBB
- Nicholas Cotton stepped down as director. NBB
- MOVENDIS stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 6 million (▲ € 5.2 million vs 2024). Source: NBB ↗
- Nicholas Cotton became a director. NBB
- Capital increase of € 790,000, published in the Gazette. Source: Staatsblad ↗
- Capital increase of € 1.5 million, published in the Gazette. Source: Staatsblad ↗
- Capital increase of € 5.6 million, published in the Gazette. Source: Staatsblad ↗
In short
From € 580,283 profit in 2022 to € 6 million profit in 2025.
Paid € 592,676 in corporate taxes since 2022.
Best year ever: 2025, with € 6 million profit.
Paid out € 830,000 in dividends to the owners in total.
Management
The stake of DR. R. VAN LANDEGHEM, Dr Irina Balikova comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
SignifeyeThe shares are held by DR. R. VAN LANDEGHEM (1.2%) and Dr Irina Balikova (0%). It owns 100% of Eqiris itself.
Directors
According to the 2025 annual accounts
Bernard Heintz
Director
Also active at: Laser Vision Clinics, PATREAN, EQIRIS, IMMO-LVC, Dokter Heintz, OAMM, Oogartsenpraktijk Brugge
since 2023 · until 2032
Nicholas Cotton
Director
since 2026 · until 2032
Shareholders
Participations
100%
Establishments
Establishment units
Physical locations of this company
Boomsesteenweg 223
2610 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Antwerpen
Same main activity (Groothandel in farmaceutische en medische artikelen), 10 active companies in Antwerpen, largest first.
€ 81.8 million revenue · 2025
€ 14.7 million revenue · 2025
€ 4.2 million gross margin · 2025
€ 194,298 gross margin · 2025
€ 75,547 gross margin · 2025
€ 35,199 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- Jean Assaf(inschrijver en inbrenger in natura) 2.7%
Incorporation
Source: Deed ↗- HEINTZ Bernard Emmanuel(oprichter) 50%
- VERDEGEM Catheline Maria Johanna Oscar José(oprichter) 50%
Details
- Company number
- 0884.161.037
- VAT number
- BE 0884.161.037
- Registered office
- Boomsesteenweg 223, 2610 Antwerpen
- Names & denominations
- Signifeye
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 October 2006
- Peppol
- Active · Active since 15 Dec 2025
- Contact
- [email protected]
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels